Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. β
Go to Publication β
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322 Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO , |
|
|
Lactobacillus acidophilus LA5 improves saturated fat-induced obesity mouse model through the enhanced intestinal Akkermansia muciniphila. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 6367 Pub: 2021 Mar 18 Epub: 2021 Mar 18 Authors Ondee T , Pongpirul K , Visitchanakun P , Saisorn W , Kanacharoen S , Wongsaroj L , Kullapanich C , Ngamwongsatit N , Settachaimongkon S , Somboonna N , Leelahavanichkul A , |
|
|
Lactobacillus acidophilus LA5 improves saturated fat-induced obesity mouse model through the enhanced intestinal Akkermansia muciniphila. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 6367 Pub: 2021 Mar 18 Epub: 2021 Mar 18 Authors Ondee T , Pongpirul K , Visitchanakun P , Saisorn W , Kanacharoen S , Wongsaroj L , Kullapanich C , Ngamwongsatit N , Settachaimongkon S , Somboonna N , Leelahavanichkul A , |
|
|
Co-Cultures of Lactobacillus acidophilus and Bacillus subtilis Enhance Mucosal Barrier by Modulating Gut Microbiota-Derived Short-Chain Fatty Acids. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 21 Pages: Pub: 2022 Oct 25 Epub: 2022 Oct 25 Authors Xie Z , Li M , Qian M , Yang Z , Han X , |
|
|
Modulation effect of Lactobacillus acidophilus KLDS 1.0738 on gut microbiota and TLR4 expression in Γ-lactoglobulin-induced allergic mice model. β
Go to Publication β
Allergologia et immunopathologia (Allergol Immunopathol (Madr) ) Vol: 48 Issue 2 Pages: 149-157 Pub: 2020 Mar-Apr Epub: 2019 Aug 30 Authors Ni WW , Zhang QM , Zhang X , Li Y , Yu SS , Wu HY , Chen Z , Li AL , Du P , Li C , |
|
|
Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 10 Issue 9 Pages: 5804-5815 Pub: 2019 Sep 1 Epub: 2019 Aug 28 Authors Yan F , Li N , Shi J , Li H , Yue Y , Jiao W , Wang N , Song Y , Huo G , Li B , |
|
|
Probiotic Lactobacillus acidophilus Strain INMIA 9602 Er 317/402 Administration Reduces the Numbers of Candida albicans and Abundance of Enterobacteria in the Gut Microbiota of Familial Mediterranean Fever Patients. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 9 Issue Pages: 1426 Pub: 2018 Epub: 2018 Jun 26 Authors Pepoyan A , Balayan M , Manvelyan A , Galstyan L , Pepoyan S , Petrosyan S , Tsaturyan V , Kamiya S , Torok T , Chikindas M , |
|
|
Benefits of heat-killed Lactobacillus acidophilus on growth performance, nutrient digestibility, antioxidant status, immunity, and cecal microbiota of rabbits. β
Go to Publication β
Frontiers in veterinary science (Front Vet Sci ) Vol: 11 Issue Pages: 1361908 Pub: 2024 Epub: 2024 Mar 1 Authors Xia M , Li C , Wu D , Wu F , Kong L , Jia Z , Han W , Chen S , Fang W , Liu Y , Chen B , |
|
|
The in vitro antimicrobial activities of metabolites from lactobacillus strains on Candida species implicated in Candida vaginitis. β
The Malaysian journal of medical sciences : MJMS (Malays J Med Sci ) Vol: 18 Issue 4 Pages: 13-25 Pub: 2011 Oct Epub: Authors Ogunshe AA , Omotoso MA , Bello VB , |
|
|
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. β
Journal of biological regulators and homeostatic agents (J Biol Regul Homeost Agents ) Vol: 28 Issue 4 Pages: 743-52 Pub: 2014 Oct-Dec Epub: Authors Orsi CF , Sabia C , Ardizzoni A , Colombari B , Neglia RG , Peppoloni S , Morace G , Blasi E , |
|
|
Antimicrobial and anti-adhesive properties of biosurfactant produced by lactobacilli isolates, biofilm formation and aggregation ability. β
The Journal of general and applied microbiology (J Gen Appl Microbiol ) Vol: 59 Issue 6 Pages: 425-36 Pub: 2013 Epub: Authors Zakaria Gomaa E , |
|
|
Γ-Glucan Alone or Combined with Lactobacillus acidophilus Positively Influences the Bacterial Diversity and Metabolites in the Colonic Microbiota of Type II Diabetic Patients. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2025 Feb 26 Epub: 2025 Feb 26 Authors Clementino JR , de Oliveira LIG , Salgaço MK , de Oliveira FL , Mesa V , Tavares JF , Silva-Pereira L , Raimundo BVB , Oliveira KC , Medeiros AI , Silva FA , Sivieri K , Magnani M , |
|
|
Modulation of microbiota, inflammation, iron status and gene expression of affected receptors in Parkinson's disease rat model by synbiotic and dark chocolate. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 15 Issue 1 Pages: 23939 Pub: 2025 Jul 4 Epub: 2025 Jul 4 Authors Al-Okbi SY , Ramadan AA , Mohamed RS , Mabrok HB , Al-Siedy ESK , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
